vzv Antibody
vzv Antibody
VZV Antibody |
|||
abx120107-05mg | Abbexa | 0.5 mg | 794.4 EUR |
VZV Gpl antibody |
|||
10-V20A | Fitzgerald | 100 ug | 430 EUR |
Description: Mouse monoclonal VZV Gpl antibody |
|||
VZV Gpl antibody |
|||
MBS530372-01mg | MyBiosource | 0.1mg | 760 EUR |
VZV Gpl antibody |
|||
MBS530372-5x01mg | MyBiosource | 5x0.1mg | 3260 EUR |
OAMA02456-v1 - VZV Antibody |
|||
OAMA02456-v1 | Aviva Systems Biology | 0.7MG | 1799 EUR |
VZV (155 kDa) Antibody |
|||
abx120101-05mg | Abbexa | 0.5 mg | 794.4 EUR |
OAMA02456-700UG - VZV Antibody |
|||
OAMA02456-700UG | Aviva Systems Biology | 0.7mg | 1799 EUR |
VZV (nucleocapsid) antibody |
|||
10-V20B | Fitzgerald | 100 ul | 254 EUR |
Description: Mouse monoclonal VZV (nucleocapsid) antibody |
|||
VZV (nucleocapsid) antibody |
|||
MBS531897-01mL | MyBiosource | 0.1mL | 440 EUR |
VZV (nucleocapsid) antibody |
|||
MBS531897-5x01mL | MyBiosource | 5x0.1mL | 1835 EUR |
Varicella Zoster Virus (VZV) Antibody |
|||
abx415760-01mg | Abbexa | 0.1 mg | 777.6 EUR |
Varicell-Zoster Virus (VZV) Antibody |
|||
GWB-A83109 | GenWay Biotech | 0.5 mg | Ask for price |
Varicell-Zoster Virus (VZV) Antibody |
|||
GWB-24B56A | GenWay Biotech | 0.5 mg | Ask for price |
Varicella-Zoster Virus (VZV) Antibody |
|||
GWB-D093E3 | GenWay Biotech | 0.5 mg | Ask for price |
Varicella Zoster Virus (VZV) Antibody (FITC) |
|||
abx411674-01mg | Abbexa | 0.1 mg | 610.8 EUR |
Varicella-Zoster Virus (VZV) gH Antibody |
|||
MBS568295-01mg | MyBiosource | 0.1mg | 455 EUR |
Varicella-Zoster Virus (VZV) gH Antibody |
|||
MBS568295-1mg | MyBiosource | 1mg | 1650 EUR |
Varicella-Zoster Virus (VZV) gH Antibody |
|||
MBS568295-5x1mg | MyBiosource | 5x1mg | 7240 EUR |
Varicella-Zoster Virus (VZV) gI Antibody |
|||
MBS568360-01mg | MyBiosource | 0.1mg | 455 EUR |
Varicella-Zoster Virus (VZV) gI Antibody |
|||
MBS568360-5x01mg | MyBiosource | 5x0.1mg | 1840 EUR |
VZV (early gene 62) antibody |
|||
10-V20C | Fitzgerald | 100 ug | 430 EUR |
Description: Mouse monoclonal VZV (early gene 62) antibody |
|||
VZV (early gene 62) antibody |
|||
MBS531845-01mg | MyBiosource | 0.1mg | 760 EUR |
VZV (early gene 62) antibody |
|||
MBS531845-5x01mg | MyBiosource | 5x0.1mg | 3260 EUR |
Varicella-Zoster Virus (VZV) Antibody (gpII) (VZVgB) |
|||
GWB-90F817 | GenWay Biotech | 0.5 mg | Ask for price |
Varicella-Zoster Virus (VZV) Antibody (gpII) (VZVgB) |
|||
GWB-A3F10B | GenWay Biotech | 0.5 mg | Ask for price |
Varicella-Zoster Virus (VZV) Antibody (gpII) (VZVgB) |
|||
GWB-110686 | GenWay Biotech | 0.5 mg | Ask for price |
Varicella-Zoster Virus (VZV) Antibody (Gene 62) |
|||
GWB-31F511 | GenWay Biotech | 0.5 mg | Ask for price |
membrane glycoprotein E (VZV) Antibody HRP Conjugated |
|||
MBS9461148-01mL | MyBiosource | 0.1mL | 595 EUR |
membrane glycoprotein E (VZV) Antibody HRP Conjugated |
|||
MBS9461148-5x01mL | MyBiosource | 5x0.1mL | 2525 EUR |
Varicella-Zoster Virus (VZV-gE) Antibody |
|||
MBS569710-01mg | MyBiosource | 0.1mg | 455 EUR |
Varicella-Zoster Virus (VZV-gE) Antibody |
|||
MBS569710-5x01mg | MyBiosource | 5x0.1mg | 1840 EUR |
Varicella-Zoster Virus (VZV) IE62 Antibody |
|||
MBS568228-01mg | MyBiosource | 0.1mg | 455 EUR |
Varicella-Zoster Virus (VZV) IE62 Antibody |
|||
MBS568228-5x01mg | MyBiosource | 5x0.1mg | 1840 EUR |
OAEF01051-100UG - Varicella-Zoster Virus (VZV- gI) Antibody |
|||
OAEF01051-100UG | Aviva Systems Biology | 100ug | 381 EUR |
Varicella Zoster Virus (VZV) nucleocapsid, Antibody |
|||
GWB-9D748B | GenWay Biotech | 0.1 mg | Ask for price |
VZV |
|||
DAG219 | Creative Diagnostics | 1 ml | 834.75 EUR |
Description: Native |
|||
VZV |
|||
DAG4708 | Creative Diagnostics | 0.25 mg | 756 EUR |
Description: Recombinant |
|||
Inactivated VZV Antigen |
|||
VAng-Lsx0550-1mg | Creative Biolabs | 1 mg | 804 EUR |
Description: VZV, native protein from MRC-5 cells. |
|||
Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (4G2) (MALS verified) |
|||
VZV-M545 | ACROBIOSYSTEMS | 100ug | 2539.7 EUR |
Description: Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix.The antibody can reacte with gE specially. |
|||
Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (4G2) (MALS verified) |
|||
VZV-M545-100ug | ACROBIOSYSTEMS | 100ug | 381.5 EUR |
Description: Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix.The antibody can reacte with gE specially. |
|||
Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (4G2) (MALS verified) |
|||
VZV-M545-1mg | ACROBIOSYSTEMS | 1mg | 2539.7 EUR |
Description: Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix.The antibody can reacte with gE specially. |
|||
Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (1B10) (MALS verified) |
|||
VZV-M544 | ACROBIOSYSTEMS | 100ug | 2539.7 EUR |
Description: Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix.The antibody can reacte with gE specially. |
|||
Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (1B10) (MALS verified) |
|||
VZV-M544-100ug | ACROBIOSYSTEMS | 100ug | 381.5 EUR |
Description: Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix.The antibody can reacte with gE specially. |
|||
Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (1B10) (MALS verified) |
|||
VZV-M544-1mg | ACROBIOSYSTEMS | 1mg | 2539.7 EUR |
Description: Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix.The antibody can reacte with gE specially. |
|||
Varicella Zoster Virus (VZV) (early gene 62), Antibody |
|||
GWB-6C668F | GenWay Biotech | 0.1 mg | Ask for price |
Biotinylated Monoclonal Anti-Glycoprotein E (VZV) Antibody, Human IgG1 (4G2) |
|||
VZV-BLM545 | ACROBIOSYSTEMS | 25ug | 1515.1 EUR |
Description: Varicella-zoster virus (VZV) is a neurotropic virus belonging to the Herpesviridae family. Primary VZV infection causes chickenpox and is followed by a life-long latent infection established mainly in the cranial and dorsal root ganglia. Reactivation of the virus is often associated with shingles (herpes zoster). Glycoprotein E (gE) is one of the known glycoproteins (gB, gC, gE, gH, gI, gK, gI) of VZV that is most abundantly expressed on the surface of virus and infected cells, playing an important role in viral replication and cell-to-cell spread. The strongly immunogenic gE can provide strong IgG signal in body fluid, which makes it ideal to be developed as an antigen for analysis of IgG antibodies. gE also demonstrates high potency as a vaccine immunogen and is formulated as the single viral envelope protein that constitutes the GSK VZV recombinant subunit vaccine Shingrix®.The antibody can reacte with gE specially. |
|||
Inactivated VZV II Antigen |
|||
VAng-0653Lsx-inquire | Creative Biolabs | inquire | Ask for price |
Description: VZV (Strain Ellen) II Antigen, inactivated by detergent. 0.29 mg/mL. |
|||
Inactivated VZV gp Antigen |
|||
VAng-Lsx0551-inquire | Creative Biolabs | inquire | Ask for price |
Description: VZV Glycoprotein, natural protein. |
|||
Varicella Zoster Virus Glycoprotein I (VZV gpl), Antibody |
|||
GWB-CB4177 | GenWay Biotech | 0.1 mg | Ask for price |
VZV/PBS ANTIGEN |
|||
MBS319900-1mL | MyBiosource | 1mL | 550 EUR |
VZV/PBS ANTIGEN |
|||
MBS319900-5x1mL | MyBiosource | 5x1mL | 2225 EUR |
OAEF01052-100UG - Varicella-Zoster Virus (VZV- MCP) Antibody |
|||
OAEF01052-100UG | Aviva Systems Biology | 100ug | 359 EUR |
VZV gE |
|||
vzv-231 | ProSpec Tany | 100µg | 165 EUR |
Description: Recombinant Varicella Zoster Virus gE |
|||
OAEF01049-100UG - Varicella-Zoster Virus (VZV-gB) Antibody |
|||
OAEF01049-100UG | Aviva Systems Biology | 100ug | 381 EUR |
OAEF01050-100UG - Varicella-Zoster Virus (VZV-gH) Antibody |
|||
OAEF01050-100UG | Aviva Systems Biology | 100ug | 381 EUR |
OAEF01053-100UG - Varicella-Zoster Virus (VZV- IE62) Antibody |
|||
OAEF01053-100UG | Aviva Systems Biology | 100ug | 381 EUR |
VZV / HHV-3 mouse monoclonal antibody, clone 5B7, FITC |
|||
BM1346F | Origene Technologies GmbH | 100 µg | Ask for price |
VZV ORF9 |
|||
vzv-232 | ProSpec Tany | 100µg | 165 EUR |
Description: Recombinant Varicella Zoster Virus ORF9 |
|||
VZV ORF26 |
|||
vzv-233 | ProSpec Tany | 100µg | 165 EUR |
Description: Recombinant Varicella Zoster Virus ORF26 |
|||
VZV protein |
|||
30-1346 | Fitzgerald | 1 mg | 200 EUR |
Description: Purified native VZV protein (Ellen strain) |
|||
VZV protein |
|||
30-AV09 | Fitzgerald | 1 ml | 394 EUR |
Description: Purified VZV protein |
|||
VZV protein |
|||
30R-AV004 | Fitzgerald | 1 ml | 610 EUR |
Description: Purified native Human VZV protein |
|||
VZV Protein |
|||
abx069975-1ml | Abbexa | 1 ml | 393.6 EUR |
VZV Protein |
|||
abx069975-25g | Abbexa | 25 g | Ask for price |
VZV Protein |
|||
abx069975-5g | Abbexa | 5 g | 662.5 EUR |
VZV Protein |
|||
abx069976-1ml | Abbexa | 1 ml | 393.6 EUR |
VZV Protein |
|||
abx069977-100g | Abbexa | 100 g | Ask for price |
VZV Protein |
|||
abx069977-1ml | Abbexa | 1 ml | 427.2 EUR |
VZV Protein |
|||
abx069977-25g | Abbexa | 25 g | 850 EUR |
VZV protein |
|||
MBS537038-1mL | MyBiosource | 1mL | 680 EUR |
VZV protein |
|||
MBS537038-5x1mL | MyBiosource | 5x1mL | 2845 EUR |
VZV protein |
|||
MBS537862-1mL | MyBiosource | 1mL | 1000 EUR |